Twinrix Adult is indicated for use in non immune adults and adolescents 16
years of age and above who are at risk of both hepatitis A and hepatitis B
infection.
Twinrix Prefilled Syringe Vaccine HEP A&B – 1ml *POM*
£56.01 + VAT
THIS PRODUCT IS A RESTRICTED ITEM. CONTACT US FOR MORE INFORMATION
Availability: In stock
£56.01 + VAT
RELATED ITEMS
-
Engerix B PFS (Hepatitis B) – 20mcg/1ml (10) *POM*
£405.43 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects.It can be expected that hepatitis D will also be prevented by immunisation with Engerix B as hepatitis D... -
MMR Vax Pro (1) *POM*
£28.52 + VATMMR stands for measles, mumps and rubella (German measles). These are three different diseases which are caused by three different viruses. The vaccines given to immunise against measles, mumps and rubella are all combined into one injection – the MMR... -
-
-
Avaxim (Hepatitis A) PFS – 0.5ml (10) *POM*
£657.24 + VATAVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above. -
Ixiaro Jap B Encephalitis Syringe – 0.5ml *POM*
£172.32 + VATIXIARO is indicated for active immunization against Japanese encephalitis in adults.IXIARO should be considered for use in individuals at risk of exposure through travel or in the course of their occupation. -
Avaxim (Hepatitis A) PFS – 0.5ml (1) *POM*
£65.75 + VATAVAXIM is indicated for active immunisation against infection caused by hepatitis A virus in susceptible adults and adolescents of 16 years of age and above. -
-
Engerix B Vial (Hepatitis B) – 20mcg/1ml (10) *POM*
£405.43 + VATEngerix B is indicated for active immunisation against hepatitis B virus infection (HBV) caused by all known subtypes in non immune subjects. The 20 µg dose vaccine in 1.0 ml suspension is intended for use in subjects 16 years of age and above. -
Vivotif Oral Typhoid Vaccine Capsule -180mg (3) *POM*
£39.93 + VATPreventing typhoid in adults and children aged six years and over. This vaccine is not given routinely – it is recommended for people travelling to areas with a high risk of typhoid.